奎斯特诊疗(DGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DGX 奎斯特诊疗

盘前交易 05-21 05:54:49 EDT

193.75

+3.36

+1.76%

最高194.85	最低190.40	成交量94.87万
今开191.87	昨收190.39	日振幅2.34%
总市值215.06亿	流通市值213.13亿	总股本1.11亿
成交额1.83亿	换手率0.86%	流通股本1.10亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DGX","market":"US","secType":"STK","nameCN":"奎斯特诊疗","latestPrice":193.75,"timestamp":1779307200000,"preClose":190.39,"halted":0,"volume":948706,"delay":0,"changeRate":0.017647985713535447,"floatShares":110000000,"shares":111000000,"eps":9.050199,"marketStatus":"盘前交易","change":3.36,"latestTime":"05-21 05:54:49 EDT","open":191.87,"high":194.85,"low":190.4,"amount":183471600.50252002,"amplitude":0.023373,"askPrice":194.69,"askSize":14,"bidPrice":192.81,"bidSize":14,"shortable":3,"etf":0,"ttmEps":9.050199,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779370200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":850798800000,"exchange":"NYSE","adjPreClose":193.75,"dividendRate":0.017123,"postHourTrading":{"tag":"盘后","latestPrice":193.75,"preClose":193.75,"latestTime":"19:35 EDT","volume":44104,"amount":8545190.28,"timestamp":1779320153848,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1126025985683925,"impliedVol":0.2031,"impliedVolPercentile":0.108},"requestUrl":"/m/hq/s/DGX","defaultTab":"news","newsList":[{"id":"1143761422","title":"异动解读 | 奎斯特诊疗盘中大涨5.09%，因第一季度业绩超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1143761422","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143761422?lang=zh_cn&edition=full","pubTime":"2026-04-21 21:33","pubTimestamp":1776778385,"startTime":"0","endTime":"0","summary":"奎斯特诊疗今日盘中大涨5.09%，引起了市场的广泛关注。消息面上，公司公布了2026财年第一季度财务报告，业绩表现强劲，超出市场预期。具体来看，第一季度调整后每股收益为2.50美元，高于分析师普遍预期的2.35美元；营收达到29.0亿美元，也高于预期的28.3亿美元。公司表示，业绩增长主要得益于常规诊断检测需求的强劲复苏。基于第一季度的优异表现和对未来业务的乐观展望，奎斯特诊疗同时上调了2026全年的业绩指引。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198000730","title":"奎斯特诊疗CEO透露：60-70%资源投入实验室自动化，AI工具提升诊断准确率与呼叫中心效率","url":"https://stock-news.laohu8.com/highlight/detail?id=1198000730","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198000730?lang=zh_cn&edition=full","pubTime":"2026-04-21 21:21","pubTimestamp":1776777674,"startTime":"0","endTime":"0","summary":"奎斯特诊疗首席执行官在电话会议中披露，公司目前将60%至70%的战略重心集中于实验室自动化领域。通过部署人工智能技术，企业不仅显著优化了诊断流程的精准度，更实现了呼叫中心运营效率的实质性跃升。这种双线并进的数字化变革，正在重塑医疗检测服务的交付模式。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","DGX","LU2506952097.USD","LU1854104046.USD","BK4583","LU0823417653.USD","LU0950375773.USD","LU1854103824.USD","BK4588","LU2506951958.HKD","LU2506951875.HKD","BK4585","LU0823417737.USD","LU2506952170.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629039386","title":"奎斯特诊疗(DGX)盘前涨3.41% 上调2026年全年业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2629039386","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629039386?lang=zh_cn&edition=full","pubTime":"2026-04-21 20:04","pubTimestamp":1776773076,"startTime":"0","endTime":"0","summary":"金吾财讯 | 奎斯特诊疗(DGX)盘前股价涨3.41%，报203美元。公司公布2026年第一季度业绩，经调整每股收益2.5美元，同比增长13.1%。期内，净收入28.95美元，同比增长9.2%。展望2026年全年，公司将净收入预测由此前的117-118.2亿美元调整至117.8-119亿美元，经调整每股收益由9.45美元调整至9.58美元。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/ZDg5MDljMjM3Zjg4MTM1NjQzMDIzNjY=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDg5MDljMjM3Zjg4MTM1NjQzMDIzNjY=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299503","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2506952170.USD","BK4196","LU1854104046.USD","LU0823417737.USD","BK4583","LU2506951958.HKD","BK4585","LU2506951875.HKD","LU0823417653.USD","LU1854103824.USD","BK4567","DGX","LU0950375773.USD","LU2506952097.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168433143","title":"奎斯特诊疗公布2026财年第一季度业绩 上调全年营收与每股收益指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1168433143","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168433143?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:47","pubTimestamp":1776768437,"startTime":"0","endTime":"0","summary":"医疗诊断服务巨头奎斯特诊疗(DGX)近日发布了2026财年第一季度财务报告，业绩表现亮眼。基于强劲的季度业绩和对未来市场的乐观预期，公司同时宣布上调2026全年的营收与每股收益(EPS)财务指引。\n第一季度财务数据显示，奎斯特诊疗在营收和盈利能力方面均实现稳健增长。这一积极态势主要得益于诊断服务需求的持续回升以及公司在运营效率方面的持续优化。\n鉴于当前业务的强劲势头和有利的市场环境，管理层决定提高对2026财年整体的业绩预期。新的指引反映了公司对核心业务增长潜力的信心，同时也考虑了其在创新诊断解决方案领域的战略布局所带来的积极影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823417653.USD","LU2506951875.HKD","DGX","LU2506951958.HKD","LU0950375773.USD","LU2506952097.USD","BK4583","LU0823417737.USD","LU1854104046.USD","BK4567","LU2506952170.USD","LU1854103824.USD","BK4588","BK4585","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179429426","title":"财报前瞻｜奎斯特诊疗本季度营收预计增7.47%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1179429426","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179429426?lang=zh_cn&edition=full","pubTime":"2026-04-14 08:40","pubTimestamp":1776127236,"startTime":"0","endTime":"0","summary":"奎斯特诊疗将于2026年04月21日美股盘前发布最新季度财报，市场关注盈利韧性与现金回报进展。一致预期显示，本季度奎斯特诊疗营收预计为28.27亿美元，同比增长7.47%；调整后每股收益预计为2.35美元，同比增长9.16%；息税前利润预计为4.15亿美元，同比增长6.07%，公司层面的毛利率与净利率或净利润指引未见披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜奎斯特诊疗本季度营收预计增7.47%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191892993","title":"异动解读 | 奎斯特诊疗盘中大涨5.09%，受强劲财报、乐观业绩指引及股东回报措施提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1191892993","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191892993?lang=zh_cn&edition=full","pubTime":"2026-02-10 22:39","pubTimestamp":1770734390,"startTime":"0","endTime":"0","summary":"奎斯特诊疗今日盘中大涨5.09%，引起了市场的广泛关注。消息面上，公司发布了2025年第四季度及全年财报，其营收和每股收益均超出市场预期。另一方面，公司宣布将季度股息上调7.5%至每股0.86美元，实现了连续十五年的股息增长，并同步宣布追加10亿美元的股票回购授权。这些积极的股东回报措施进一步增强了投资者信心，共同推动了股价的显著上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610207586","title":"奎斯特诊疗涨4.68% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2610207586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610207586?lang=zh_cn&edition=full","pubTime":"2026-02-10 22:34","pubTimestamp":1770734066,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日22时34分，奎斯特诊疗股票出现异动，股价快速上涨4.68%。截至发稿，该股报200.20美元/股，成交量9.5785万股，换手率0.09%，振幅4.24%。奎斯特诊疗股票所在的生命科学行业中，整体跌幅为0.05%。其相关个股中，Personalis, Inc.、Precipio, Inc.、奎斯特诊疗涨幅较大，Ispecimen Inc.、Xwell, Inc.、Mainz Biomed N.V.较为活跃，换手率分别为0.73%、0.33%、0.33%，振幅较大的相关个股有Precipio, Inc.、Prenetics Global、奎斯特诊疗，振幅分别为7.22%、6.20%、4.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021022342697a5a9e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021022342697a5a9e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4567","LU2506951875.HKD","DGX","BK4588","LU2506952097.USD","LU2506951958.HKD","LU1854103824.USD","LU1854104046.USD","LU0950375773.USD","BK4585","BK4196","LU0823417653.USD","BK4583","LU2506952170.USD","LU0823417737.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136248766","title":"奎斯特诊疗高管确认：基于上周联邦资金法案通过，2026年PAMA将无影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1136248766","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136248766?lang=zh_cn&edition=full","pubTime":"2026-02-10 21:50","pubTimestamp":1770731418,"startTime":"0","endTime":"0","summary":"奎斯特诊疗高管在电话会议中明确表示，随着上周联邦资金立法案的顺利通过，2026年《保护医保准入法案》将不会对公司运营产生任何影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","BK4588","LU0823417653.USD","LU1854103824.USD","LU0823417737.USD","LU2506952097.USD","BK4585","BK4196","DGX","LU1854104046.USD","LU2506952170.USD","LU2506951958.HKD","BK4583","LU2506951875.HKD","LU0950375773.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127532242","title":"奎斯特诊疗公布2025年第四季度及全年财报 发布2026年度业绩指引 季度股息上调7.5%至每股0.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127532242","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127532242?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:48","pubTimestamp":1770724096,"startTime":"0","endTime":"0","summary":"奎斯特诊疗近日披露了2025年第四季度及全年财务业绩报告，同时公布了2026年全年的业绩展望。公司宣布将季度股息提高7.5%，达到每股0.86美元，展现出对股东回报的持续承诺。\n财报数据显示，公司在2025年第四季度及全年均实现了稳健的财务表现。此次股息上调反映了管理层对未来现金流生成能力的信心，以及对平衡业务增长与股东收益的战略考量。\n在2026年业绩指引中，奎斯特诊疗基于当前市场环境和业务发展趋势，提出了具体的财务目标。这一指引将为投资者评估公司未来增长潜力提供重要参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","DGX","LU2506952097.USD","LU1854104046.USD","BK4583","LU0823417653.USD","LU0950375773.USD","LU1854103824.USD","BK4588","LU2506951958.HKD","LU2506951875.HKD","BK4585","LU0823417737.USD","LU2506952170.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167905120","title":"奎斯特诊疗季度股息上调7.5%至0.86美元，实现连续十五年增长；同步宣布追加10亿美元股票回购授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1167905120","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167905120?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:33","pubTimestamp":1770723213,"startTime":"0","endTime":"0","summary":"奎斯特诊疗宣布将季度股息提高7.5%，达到每股0.86美元，这标志着该公司已实现连续十五年股息增长。与此同时，企业还公布了股票回购授权额度增加10亿美元的重大决策。股息持续上调凸显了管理层对现金流稳定性的信心，而回购计划扩容则进一步表明其致力于通过资本回报优化股东价值的战略意图。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854103824.USD","BK4588","BK4196","LU2506951875.HKD","BK4583","LU2506952097.USD","BK4585","BK4567","LU0950375773.USD","LU0823417737.USD","LU0823417653.USD","LU2506951958.HKD","DGX","LU2506952170.USD","LU1854104046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197909655","title":"财报前瞻 ｜奎斯特诊疗本季度营收预计温和增长，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1197909655","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197909655?lang=zh_cn&edition=full","pubTime":"2026-02-03 10:19","pubTimestamp":1770085142,"startTime":"0","endTime":"0","summary":"奎斯特诊疗预计将于2026年02月10日公布新一季财报，市场预期本季度营收与盈利保持稳健增长，关注常规检测量恢复与价格结构优化的共同驱动。- 市场一致预期显示，本季度奎斯特诊疗总收入预计为27.54亿美元，同比增长6.80%；息税前利润预计为4.20亿美元，同比增长10.02%；调整后每股收益预计为2.36美元，同比增长7.97%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜奎斯特诊疗本季度营收预计温和增长，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592249749","title":"微星EdgeXpert散热优化显成效 推理速度超英伟达DGX Spark一成","url":"https://stock-news.laohu8.com/highlight/detail?id=2592249749","media":"ITBEAR科技资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592249749?lang=zh_cn&edition=full","pubTime":"2025-12-18 13:06","pubTimestamp":1766034381,"startTime":"0","endTime":"0","summary":"英伟达近日面向AI计算市场推出GB10超级芯片解决方案，引发行业广泛关注。基于该芯片打造的DGX Spark作为第一方\"FE公版\"设备，已与多家PC厂商推出的非公版GB10迷你主机形成竞争格局。微星科技推出的EdgeXpert主机在散热架构上展现独特创新，其搭载的均热板配合三根热管与铜质鳍片，形成立体化导热系统。在GPT OSS 120B模型推理测试中，EdgeXpert较英伟达原厂设备展现出10%的性能优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218132130a459e995&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218132130a459e995&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVD","NVDA","BK4550","LU1548497426.USD","LU1720051108.HKD","IE00BQXX3C00.GBP","2NVD.UK","LU1323610961.USD","NVIW.SI","NVDY","LU1316542783.SGD","IE00BKDWB100.SGD","IE0004445239.USD","LU2413666699.HKD","BK4529","IE00B19Z8W00.USD","LU2430703251.USD","IE00B4YYXB79.USD","IE00BKVL7J92.USD","NVDD","BK4527","BK4579","NVDS","LU0950375773.USD","SGXZ31699556.SGD","LU0823434740.USD","LU0289739343.SGD","LU2023250330.USD","SNVD.UK","LU0823417653.USD","NVD3.UK","3NVD.UK","LU0056508442.USD","DGX","LU0061474705.USD","LU1935042488.USD","LU0557290698.USD","NVD2.UK","IE00B775H168.HKD","LU0276348264.USD","LU0444973449.USD","NVDU","LU2552382132.HKD","LU2168564149.EUR","NVDX","LU1261432733.SGD","NVDS.UK","LU1983260115.SGD","LU0175139822.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2588885228","title":"黄仁勋：当年英伟达首款 AI 超算 DGX-1 问世时没人想买，除了马斯克","url":"https://stock-news.laohu8.com/highlight/detail?id=2588885228","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588885228?lang=zh_cn&edition=full","pubTime":"2025-12-04 19:10","pubTimestamp":1764846604,"startTime":"0","endTime":"0","summary":"IT之家 12 月 4 日消息，英伟达 CEO 黄仁勋日前在《The Joe Rogan Experience》中露面，并谈到英伟达打造首款 AI 机器时的经历：投入巨额成本，但市场兴趣几乎为零，直到马斯克站出来改变局面。当时 AI 计算尚未兴起，行业仍专注于基于 CPU 的计算任务，这也是 DGX-1 最初无人问津的原因。相关阅读：《马斯克谈 OpenAI：它变了，变得面目全非》《英伟达发布全新深度学习超算：DGX-1》《深度学习超算 DGX-1 售价公布：129000 美元，现在起接受预定》","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204191737a723a9cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204191737a723a9cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1992135399.USD","LU2242649171.HKD","NVDS","NVDX","DXYZ","SG9999002224.SGD","SNVD.UK","LU1935043023.USD","LU0472753341.HKD","DGX","IE00BMPRXR70.SGD","2NVD.UK","LU0289960550.SGD","NVDU","LU1917777945.USD","LU0310800379.SGD","BK4554","UFO","LU1316542783.SGD","LU1821325948.USD","NVD","LU0708994859.HKD","NVDY","TSYW.SI","NVIW.SI","NVDA","LU2237957902.USD","BK4551","LU2083900584.USD","BK4516","BK4196","LU0077335932.USD","LU1923622291.USD","LU1791710582.SGD","NVDD","LU0158827948.USD","NVD3.UK","IE00BKVL7J92.USD","NVDS.UK","IE00BDRTCR15.USD","3NVD.UK","NVD2.UK","LU1280957306.USD","LU1127390331.HKD","IE00B3M56506.USD","LU0979878070.USD","LU0823434740.USD","LU0868494708.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2508512138","title":"瑞穗银行：维持Quest Diagnostics(DGX.US)评级，由优于大市调整至优于大市评级, 目标价由177.00美元调整至178.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508512138","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508512138?lang=zh_cn&edition=full","pubTime":"2025-02-04 02:19","pubTimestamp":1738606781,"startTime":"0","endTime":"0","summary":"瑞穗银行：维持Quest Diagnostics(DGX.US)评级，由优于大市调整至优于大市评级, 目标价由177.00美元调整至178.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/04021947942438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["161121","DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508967767","title":"Truist Securities：维持Quest Diagnostics(DGX.US)评级，由持有调整至持有评级, 目标价由172.00美元调整至182.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508967767","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508967767?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:33","pubTimestamp":1738341205,"startTime":"0","endTime":"0","summary":"Truist Securities：维持Quest Diagnostics(DGX.US)评级，由持有调整至持有评级, 目标价由172.00美元调整至182.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/01003347922409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508964727","title":"奎斯特诊疗2024财年实现净利润8.66亿美元，同比增加1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508964727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508964727?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:00","pubTimestamp":1738339240,"startTime":"0","endTime":"0","summary":"2月1日，奎斯特诊疗公布财报，公告显示公司2024财年净利润为8.66亿美元，同比增加1.88%；其中营业收入为98.72亿美元，同比增加6.70%，每股基本收益为7.80美元。从资产负债表来看，奎斯特诊疗总负债92.57亿美元，其中短期债务7.75亿美元，资产负债比为1.75，流动比率为1.11。机构评级：截至2025年2月1日，当前有15家机构对奎斯特诊疗目标价做出预测，其中目标均价为176.67美元，其中最低目标价为160.00美元，最高目标价为190.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201000055abbe4c05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201000055abbe4c05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507965630","title":"巴克莱：维持Quest Diagnostics(DGX.US)评级，由持股观望调整至持股观望评级, 目标价由168.00美元调整至175.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507965630","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507965630?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:28","pubTimestamp":1738333727,"startTime":"0","endTime":"0","summary":"巴克莱：维持Quest Diagnostics(DGX.US)评级，由持股观望调整至持股观望评级, 目标价由168.00美元调整至175.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/31222847921853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104196404","title":"异动解读 | 奎斯特诊疗2024年Q4财报表现出色,盘中股价大涨5.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104196404","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104196404?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:41","pubTimestamp":1738248110,"startTime":"0","endTime":"0","summary":"奎斯特诊疗今日盘中股价大涨5.1%,报收于144.26美元。引发该股价大涨的主因是该公司2024年第四季度业绩表现优异,超出市场预期。根据财报显示,奎斯特诊疗第四季度营收同比增长14.6%至26.2亿美元,高于分析师预期的25.8亿美元;调整后每股收益2.23美元,也超出了分析师平均预期的2.19美元。业绩超预期的主要原因是消费者对于诊断测试需求强劲。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507213826","title":"奎斯特诊疗盘中异动 早盘大幅上涨5.25%报163.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507213826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507213826?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:38","pubTimestamp":1738247883,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时38分，奎斯特诊疗股票出现波动，股价大幅拉升5.25%。截至发稿，该股报163.60美元/股，成交量9.0837万股，换手率0.08%，振幅5.63%。奎斯特诊疗股票所在的生命科学行业中，整体涨幅为3.80%。其相关个股中，Personalis, Inc.、赛默飞世尔、奎斯特诊疗涨幅较大，Mainz Biomed N.V.、Ispecimen Inc.、Check-Cap Ltd.较为活跃，换手率分别为1.04%、0.50%、0.19%，振幅较大的相关个股有Check-Cap Ltd.、Bioaffinity Technologies, Inc.、奎斯特诊疗，振幅分别为9.09%、6.28%、5.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223804a2345694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223804a2345694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","DGX","LU1854104046.USD","LU1854103824.USD","BK4585","BK4588","BK4567","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507264426","title":"Quest Diagnostics(DGX.US)：2024年Q4财报实现营收26.21亿美元，前值为22.88亿美元，预期值为25.8亿美元；每股收益为2.23美元，前值为2.15美元，预期值为2.18美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507264426","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507264426?lang=zh_cn&edition=full","pubTime":"2025-01-30 19:54","pubTimestamp":1738238063,"startTime":"0","endTime":"0","summary":"Quest Diagnostics(DGX.US)：2024年Q4财报实现营收26.21亿美元，前值为22.88亿美元，预期值为25.8亿美元；每股收益为2.23美元，前值为2.15美元，预期值为2.18美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30195447908900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.questdiagnostics.com","stockEarnings":[{"period":"1week","weight":0.0152},{"period":"1month","weight":-0.013},{"period":"3month","weight":-0.0429},{"period":"6month","weight":0.0131},{"period":"1year","weight":0.087},{"period":"ytd","weight":0.1165}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.0459},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.2503},{"period":"ytd","weight":0.087}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"奎斯特诊疗公司于1990年在特拉华州成立。公司是全球领先的诊断信息服务提供商。公司在医疗生态系统中扮演着至关重要的角色，使人们能够采取行动改善健康状况。来自世界上最大的临床实验室结果数据库，其诊断见解揭示了识别和治疗疾病、激励健康行为和改善医疗管理的新途径。在正确的人和正确的背景下，它的诊断性见解可以激发改变生活的行动。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":-0.005455},{"month":2,"riseRate":0.433333,"avgChangeRate":0.001785},{"month":3,"riseRate":0.666667,"avgChangeRate":0.019788},{"month":4,"riseRate":0.666667,"avgChangeRate":0.068015},{"month":5,"riseRate":0.7,"avgChangeRate":0.028478},{"month":6,"riseRate":0.655172,"avgChangeRate":0.02586},{"month":7,"riseRate":0.413793,"avgChangeRate":-0.009365},{"month":8,"riseRate":0.551724,"avgChangeRate":-0.00294},{"month":9,"riseRate":0.413793,"avgChangeRate":-0.005902},{"month":10,"riseRate":0.482759,"avgChangeRate":-0.003486},{"month":11,"riseRate":0.827586,"avgChangeRate":0.033687},{"month":12,"riseRate":0.689655,"avgChangeRate":0.023389}],"exchange":"NYSE","name":"奎斯特诊疗","nameEN":"Quest Diagnostics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奎斯特诊疗(DGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奎斯特诊疗(DGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奎斯特诊疗,DGX,奎斯特诊疗股票,奎斯特诊疗股票老虎,奎斯特诊疗股票老虎国际,奎斯特诊疗行情,奎斯特诊疗股票行情,奎斯特诊疗股价,奎斯特诊疗股市,奎斯特诊疗股票价格,奎斯特诊疗股票交易,奎斯特诊疗股票购买,奎斯特诊疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奎斯特诊疗(DGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奎斯特诊疗(DGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}